Fundraising FoxBiotech Startups
11,050 companies tagged Biotech, with their investors and founders.
0 investors
Creative Medical Technology Holdings (CELZ) is a biotechnology company developing regenerative medicine and immunotherapy platforms for conditions in immunology, endocrinology, urogynecology, and orthopedics. Its technologies include autologous immunotherapy (ImmCelz), an allogenic cell platform (AlloStem), a cellular reprogramming platform (iPSCELZ), and rapid autologous therapy programs (StemSpine, OvaStem, CaverStem).
0 investors
Credence MedSystems develops drug delivery and medical device technologies for pharmaceutical manufacturers and healthcare providers. The company is led by executives with extensive backgrounds in medical technology commercialization and surgical device innovation.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
CryoLife develops technologies for aortic treatment, positioning itself in the cardiovascular medical device field.
0 investors
Cryoport provides temperature-controlled supply chain solutions, cryogenic storage systems, and biostorage and sample processing services for the Life Sciences industry, with a focus on cell and gene therapy. It serves biopharmaceutical, animal husbandry, and reproductive medicine companies, as well as universities, research institutions, and government agencies across the Americas, EMEA, and APAC.
0 investors
CryptoMedix Inc. is a pre-clinical biotech developing first-in-class therapeutic antibodies (CMX-101 and CMX-102) targeting the tumor microenvironment for immuno-oncology, promoting cytotoxic T-cell activity and interacting with immune checkpoints such as PD(L)1 and LAG-3. Its CMX-102 antibody is also positioned for use as antibody-drug conjugates and radionuclide conjugates targeting tumor cells.
0 investors
0 investors
0 investors
0 investors
Cue Biopharma is a precision immunotherapy company developing engineered therapies targeting allergic and autoimmune diseases. The company's pipeline includes CUE-221 for IgE-mediated allergic disease and CUE-401 advancing from its proprietary Immuno-STAT platform for autoimmune conditions.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors